In the press
New Podcast Launched
We are ecstatic to announce that we have launched our new podcast “OGB Podcast” on both Spotify and Anchor.
We will be talking to industry leaders about the state of the biotech industry as well as delving into the specifics of our guests expertise. You can find and listen to us on Spotify ( https://open.spotify.com/show/0tSRtB4tFUcqHhW43RkWIL ) as well as Anchor ( https://anchor.fm/marc-appel9 ).
Related Press
IF HENRY FORD WERE IN BIOTECH
IF HENRY FORD WERE IN BIOTECH Please join us to hear from our CEO, Marc Appel.
Cronicle Tech News
Cronicle Tech News The following was taken from the Cronicle written by Lauren K. Cowan. Check out the original piece here: https://cronicle.press/2021/03/08/ann-arbors-asalyxa-bio-raises-2-million-to-start-clinical-trials-for-neutrophil-targeting-drug-delivery-tech/ Research Bridge Partners – a 501 (c) (3) organization that bridges preeminent innovators at mid-continent research universities Asalyxa Bio, Inc., a biopharmaceutical startup developing nano-engineered, immune cell-targeted therapeutics, just announced the closing of… Continue reading Cronicle Tech News
1819 Innovation Hub tenant inks key partnership with Korea VC firm
1819 Innovation Hub tenant inks key partnership with Korea VC firm The following excerpt was taken from TechOhio– continue reading here. A biotech firm that moved its headquarters from New York to Cincinnati in late 2021 has announced its first major collaboration A biotech firm that moved its headquarters from New York to Cincinnati in… Continue reading 1819 Innovation Hub tenant inks key partnership with Korea VC firm
Magnuson Center for Entrepreneurship at Dartmouth College and Orange Grove Bio Establish Collaboration
Magnuson Center for Entrepreneurship at Dartmouth College and Orange Grove Bio Establish Collaboration to Strengthen Biotech Ecosystem and Support Development and Commercialization of Novel Therapeutics The following excerpt was taken from Globenewswire– continue reading here. Orange Grove Bio, a drug investment and development firm, today announced the establishment of a strategic collaboration with the Magnuson… Continue reading Magnuson Center for Entrepreneurship at Dartmouth College and Orange Grove Bio Establish Collaboration
Orange Grove Bio and Cincinnati Children’s Hospital Medical Center Establish Collaboration
Orange Grove Bio, a preclinical drug investment and development firm, and Cincinnati
Wall Street Journal
Wall Street Journal The following was taken from the Wall Street Journal. Check out the original piece here: https://www.wsj.com/articles/vc-daily-biotechs-test-new-company-building-model-11614261635 We are incredibly excited and humbled to be recognized in the Wall Street Journal for our innovative business model! We thank everyone who has been supporting us from the beginning.
Our first portfolio company, Asalyxa Bio, has launched
Our first portfolio company, Asalyxa Bio, has launched. The University of Michigan, our partner in the creation of this company, released a press release which can be read below. — Asalyxa Bio, a startup with neutrophil targeting drug-delivery technology invented at University of Michigan Asalyxa Bio, a startup with neutrophil targeting drug-delivery technology invented at… Continue reading Our first portfolio company, Asalyxa Bio, has launched
Upcoming Webinar for Pre-Clinical Biotech Development Opportunities on April 16th at 1 PM EST.
Upcoming Webinar for Pre-Clinical Biotech Development Opportunities on April 16th at 1 PM EST. Please join us to hear from our CEO, Marc Appel.– continue reading here. Upcoming Webinar for Pre-Clinical Biotech Development Opportunities
New Partnership Continues Pitt’s Turn Toward Commercializing Research
New Partnership Continues Pitt’s Turn Toward Commercializing Research The following excerpt was taken from Pittsburgh Post-Gazette — continue reading here. An Ohio drug investment and development firm is partnering with the University of Pittsburgh to commercialize therapies “An Ohio drug investment and development firm is partnering with the University of Pittsburgh to commercialize therapies targeting… Continue reading New Partnership Continues Pitt’s Turn Toward Commercializing Research